Case report: Difficult diagnosis of Mycobacterium tuberculosis infection in patients after allogeneic hematopoietic stem cell transplantation: two case reports and a literature review
- PMID: 38863639
- PMCID: PMC11165128
- DOI: 10.3389/fonc.2024.1283320
Case report: Difficult diagnosis of Mycobacterium tuberculosis infection in patients after allogeneic hematopoietic stem cell transplantation: two case reports and a literature review
Abstract
Background: Mycobacterium tuberculosis (MTB) is a relatively infrequent infection encountered during hematopoietic stem-cell transplantation (HSCT). The identification of MTB following HSCT remains a complex task, with delayed detection and misdiagnosis potentially resulting in unfavorable outcomes. Metagenomic next-generation sequencing (mNGS) represents a novel, highly sensitive, and rapid diagnostic tool in clinical settings for discerning intricate infections and detecting exceedingly rare pathogens.
Methods: With the aid of mNGS, we diagnosed MTB in the lymph nodes and lungs of two patients with hematological diseases following allogeneic peripheral blood hematopoietic stem cell transplantation. Both patients presented with a fever, localized symptoms, and clinical signs. Following inconclusive results from routine tests, impractical biopsy procedures, and unsuccessful responses to empirical treatments, mNGS was employed as a final recourse, revealing DNA fragments of MTB in blood samples.
Results: The diagnoses were ultimately confirmed in conjunction with additional clinical evidence. The application of mNGS in MTB cases after allogeneic HSCT has rarely been reported. The mNGS technique can provide a prompt and highly sensitive indication leading to the definitive diagnosis of MTB in complex post-transplant scenarios.
Keywords: allo-HSCT; MTB (Mycobacterium tuberculosis); case report; diagnosis; mNGS (metagenomic next-generation sequencing).
Copyright © 2024 Liu, Cai and Su.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Application of metagenomic next-generation sequencing in the clinical diagnosis of infectious diseases after allo-HSCT: a single-center analysis.BMC Infect Dis. 2024 Mar 4;24(1):279. doi: 10.1186/s12879-024-09153-y. BMC Infect Dis. 2024. PMID: 38438967 Free PMC article.
-
Metagenomic Next-Generation Sequencing vs. Traditional Pathogen Detection in the Diagnosis of Infection After Allogeneic Hematopoietic Stem Cell Transplantation in Children.Front Microbiol. 2022 Apr 18;13:868160. doi: 10.3389/fmicb.2022.868160. eCollection 2022. Front Microbiol. 2022. PMID: 35509305 Free PMC article.
-
Clinical Evaluation of Diagnosis Efficacy of Active Mycobacterium tuberculosis Complex Infection via Metagenomic Next-Generation Sequencing of Direct Clinical Samples.Front Cell Infect Microbiol. 2019 Oct 18;9:351. doi: 10.3389/fcimb.2019.00351. eCollection 2019. Front Cell Infect Microbiol. 2019. PMID: 31681628 Free PMC article.
-
Rapid diagnosis of Talaromyces marneffei infection by metagenomic next-generation sequencing technology in a Chinese cohort of inborn errors of immunity.Front Cell Infect Microbiol. 2022 Sep 8;12:987692. doi: 10.3389/fcimb.2022.987692. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36159645 Free PMC article.
-
Application of Metagenomic Next-Generation Sequencing in Mycobacterium tuberculosis Infection.Front Med (Lausanne). 2022 Apr 1;9:802719. doi: 10.3389/fmed.2022.802719. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35433724 Free PMC article.
Cited by
-
Successful Management of Active Tuberculosis During Allogeneic Hematopoietic Stem Cell Transplantation in a Patient With Relapsed Acute Myeloid Leukemia: A Case Report and Literature Review.Cureus. 2025 Apr 10;17(4):e82026. doi: 10.7759/cureus.82026. eCollection 2025 Apr. Cureus. 2025. PMID: 40352017 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources